Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
1753 | 6481 | 45.7 | 87% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
11 | 4 | NEUROSCIENCES//CLINICAL NEUROLOGY//NEUROL | 1112395 |
133 | 3 | MELATONIN//SLEEP//JOURNAL OF PINEAL RESEARCH | 66554 |
1753 | 2 | OREXIN//GALANIN//HYPOCRETIN | 6481 |
2754 | 1 | OREXIN//HYPOCRETIN//OREXIN A | 2157 |
3375 | 1 | GALANIN//GALANIN RECEPTOR//GALANIN LIKE PEPTIDE | 1998 |
13418 | 1 | MELANIN CONCENTRATING HORMONE//MCH//MCH R1 ANTAGONISTS | 838 |
20265 | 1 | CART PEPTIDE//COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT//CART | 468 |
22727 | 1 | NESFATIN 1//NUCB2//NUCLEOBINDIN 2 | 371 |
27049 | 1 | NEUROMEDIN U//NEUROMEDIN S//NMUR2 | 239 |
27794 | 1 | NPSR//NPSR1//NEUROPEPTIDE S RECEPTOR | 221 |
33785 | 1 | NEUROPEPTIDE W//GPR7//NEUROPEPTIDE B | 120 |
36991 | 1 | ECRG4//ESOPHAGEAL CANCER RELATED GENE 4//SPEXIN | 69 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | OREXIN | authKW | 2581112 | 12% | 68% | 808 |
2 | GALANIN | authKW | 2435968 | 12% | 66% | 780 |
3 | HYPOCRETIN | authKW | 1251655 | 6% | 64% | 416 |
4 | MELANIN CONCENTRATING HORMONE | authKW | 928292 | 4% | 79% | 248 |
5 | OREXIN A | authKW | 915048 | 4% | 84% | 232 |
6 | NESFATIN 1 | authKW | 592891 | 2% | 87% | 145 |
7 | GALANIN RECEPTOR | authKW | 476352 | 2% | 96% | 105 |
8 | MCH | authKW | 374605 | 2% | 66% | 120 |
9 | OREXIN RECEPTORS | authKW | 338651 | 1% | 90% | 80 |
10 | NEUROMEDIN U | authKW | 307536 | 1% | 82% | 80 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Neurosciences | 35862 | 44% | 0% | 2826 |
2 | Endocrinology & Metabolism | 26072 | 25% | 0% | 1622 |
3 | Pharmacology & Pharmacy | 4312 | 17% | 0% | 1111 |
4 | Physiology | 3300 | 9% | 0% | 561 |
5 | Behavioral Sciences | 1485 | 4% | 0% | 250 |
6 | Biochemistry & Molecular Biology | 1374 | 16% | 0% | 1058 |
7 | Chemistry, Medicinal | 1023 | 4% | 0% | 290 |
8 | Psychiatry | 298 | 4% | 0% | 233 |
9 | Psychology, Biological | 229 | 1% | 0% | 52 |
10 | Cell Biology | 187 | 5% | 0% | 321 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOL NEUROSCI INTEGRAT PHYSIOL | 172502 | 1% | 72% | 51 |
2 | INTEGRAT NEUROENDOCRINOL | 55390 | 0% | 59% | 20 |
3 | NARCOLEPSY | 52394 | 1% | 26% | 43 |
4 | LAURA BASSI EXPERTISE THER EP | 51276 | 0% | 78% | 14 |
5 | NEUROCHEM NEUROTOXICOL | 36996 | 1% | 21% | 37 |
6 | CHEM NEUROANAT | 36311 | 0% | 43% | 18 |
7 | COMBINING CHINESE TRADIT WESTERN MED | 36223 | 0% | 77% | 10 |
8 | YANAGISAWA ORPHAN RECEPTOR PROJECT | 27956 | 0% | 42% | 14 |
9 | CHARITE INTERNAL MED DERMATOL | 24274 | 0% | 37% | 14 |
10 | EXPLORATORY ADV TECHNOL YANAGISAWA ORPHAN REC | 24219 | 0% | 86% | 6 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | PEPTIDES | 52402 | 5% | 4% | 313 |
2 | NEUROPEPTIDES | 46120 | 2% | 6% | 158 |
3 | REGULATORY PEPTIDES | 32822 | 3% | 4% | 182 |
4 | JOURNAL OF NEUROENDOCRINOLOGY | 15290 | 2% | 3% | 102 |
5 | JOURNAL OF CHEMICAL NEUROANATOMY | 8452 | 1% | 4% | 48 |
6 | NEUROSCIENCE | 7635 | 3% | 1% | 192 |
7 | NEUROSCIENCE LETTERS | 7480 | 4% | 1% | 227 |
8 | BRAIN RESEARCH | 6047 | 4% | 1% | 254 |
9 | ENDOCRINOLOGY | 5620 | 3% | 1% | 176 |
10 | VITAMINS AND HORMONES | 4333 | 0% | 6% | 15 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | OREXIN | 2581112 | 12% | 68% | 808 | Search OREXIN | Search OREXIN |
2 | GALANIN | 2435968 | 12% | 66% | 780 | Search GALANIN | Search GALANIN |
3 | HYPOCRETIN | 1251655 | 6% | 64% | 416 | Search HYPOCRETIN | Search HYPOCRETIN |
4 | MELANIN CONCENTRATING HORMONE | 928292 | 4% | 79% | 248 | Search MELANIN+CONCENTRATING+HORMONE | Search MELANIN+CONCENTRATING+HORMONE |
5 | OREXIN A | 915048 | 4% | 84% | 232 | Search OREXIN+A | Search OREXIN+A |
6 | NESFATIN 1 | 592891 | 2% | 87% | 145 | Search NESFATIN+1 | Search NESFATIN+1 |
7 | GALANIN RECEPTOR | 476352 | 2% | 96% | 105 | Search GALANIN+RECEPTOR | Search GALANIN+RECEPTOR |
8 | MCH | 374605 | 2% | 66% | 120 | Search MCH | Search MCH |
9 | OREXIN RECEPTORS | 338651 | 1% | 90% | 80 | Search OREXIN+RECEPTORS | Search OREXIN+RECEPTORS |
10 | NEUROMEDIN U | 307536 | 1% | 82% | 80 | Search NEUROMEDIN+U | Search NEUROMEDIN+U |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | LANG, R , GUNDLACH, AL , HOLMES, FE , HOBSON, SA , WYNICK, D , HOKFELT, T , KOFLER, B , (2015) PHYSIOLOGY, SIGNALING, AND PHARMACOLOGY OF GALANIN PEPTIDES AND RECEPTORS: THREE DECADES OF EMERGING DIVERSITY.PHARMACOLOGICAL REVIEWS. VOL. 67. ISSUE 1. P. 118 -175 | 556 | 75% | 31 |
2 | LANG, R , GUNDLACH, AL , KOFLER, B , (2007) THE GALANIN PEPTIDE FAMILY: RECEPTOR PHAN-NACOLOGY, PLEIOTROPIC BIOLOGICAL ACTIONS, AND IMPLICATIONS IN HEALTH AND DISEASE.PHARMACOLOGY & THERAPEUTICS. VOL. 115. ISSUE 2. P. 177 -207 | 331 | 89% | 167 |
3 | LI, JC , HU, Z , DE LECEA, L , (2014) THE HYPOCRETINS/OREXINS: INTEGRATORS OF MULTIPLE PHYSIOLOGICAL FUNCTIONS.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 171. ISSUE 2. P. 332-350 | 269 | 90% | 43 |
4 | KUKKONEN, JP , (2013) PHYSIOLOGY OF THE OREXINERGIC/HYPOCRETINERGIC SYSTEM: A REVISIT IN 2012.AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY. VOL. 304. ISSUE 1. P. C2-C32 | 315 | 78% | 41 |
5 | GOTTER, AL , WEBBER, AL , COLEMAN, PJ , RENGER, JJ , WINROW, CJ , (2012) INTERNATIONAL UNION OF BASIC AND CLINICAL PHARMACOLOGY. LXXXVI. OREXIN RECEPTOR FUNCTION, NOMENCLATURE AND PHARMACOLOGY.PHARMACOLOGICAL REVIEWS. VOL. 64. ISSUE 3. P. 389 -420 | 243 | 83% | 51 |
6 | CHEN, QH , DE LECEA, L , HU, ZA , GAO, D , (2015) THE HYPOCRETIN/OREXIN SYSTEM: AN INCREASINGLY IMPORTANT ROLE IN NEUROPSYCHIATRY.MEDICINAL RESEARCH REVIEWS. VOL. 35. ISSUE 1. P. 152 -197 | 253 | 71% | 8 |
7 | SUBHEDAR, NK , NAKHATE, KT , UPADHYA, MA , KOKARE, DM , (2014) CART IN THE BRAIN OF VERTEBRATES: CIRCUITS, FUNCTIONS AND EVOLUTION.PEPTIDES. VOL. 54. ISSUE . P. 108 -130 | 220 | 67% | 18 |
8 | LEONARD, CS , KUKKONEN, JP , (2014) OREXIN/HYPOCRETIN RECEPTOR SIGNALLING: A FUNCTIONAL PERSPECTIVE.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 171. ISSUE 2. P. 294-313 | 161 | 86% | 18 |
9 | LOPEZ, M , TENA-SEMPERE, M , DIEGUEZ, C , (2010) CROSS-TALK BETWEEN OREXINS (HYPOCRETINS) AND THE NEUROENDOCRINE AXES (HYPOTHALAMIC-PITUITARY AXES).FRONTIERS IN NEUROENDOCRINOLOGY. VOL. 31. ISSUE 2. P. 113-127 | 216 | 75% | 22 |
10 | SAKURAI, T , (2014) THE ROLE OF OREXIN IN MOTIVATED BEHAVIOURS.NATURE REVIEWS NEUROSCIENCE. VOL. 15. ISSUE 11. P. 719 -731 | 127 | 88% | 49 |
Classes with closest relation at Level 2 |